Copyright Reports & Markets. All rights reserved.

Global Breakthrough Therapy (BT) Designation Market Research Report 2012-2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Objectives of Research
      • 1.1.1 Definition
      • 1.1.2 Specifications
    • 1.2 Market Segment
      • 1.2.1 by Type
        • 1.2.1.1 Oncology
        • 1.2.1.2 Infectious Diseases
        • 1.2.1.3 Rare Diseases
        • 1.2.1.4 Autoimmune Diseases
        • 1.2.1.5 Pulmonary Diseases
        • 1.2.1.6 Neurological Disorders
        • 1.2.1.7 Others
      • 1.2.2 by Application
        • 1.2.2.1 Hospital
        • 1.2.2.2 Clinic
        • 1.2.2.3 Research Institute
        • 1.2.2.4 Laboratories
      • 1.2.3 by Regions

    2 Industry Chain

    • 2.1 Industry Chain Structure
    • 2.2 Upstream
    • 2.3 Market
      • 2.3.1 SWOT
      • 2.3.2 Dynamics

    3 Environmental Analysis

    • 3.1 Policy
    • 3.2 Economic
    • 3.3 Technology
    • 3.4 Market Entry

    4 Market Segmentation by Type

    • 4.1 Market Size
      • 4.1.1 Oncology Market, 2013-2018
      • 4.1.2 Infectious Diseases Market, 2013-2018
      • 4.1.3 Rare Diseases Market, 2013-2018
      • 4.1.4 Autoimmune Diseases Market, 2013-2018
      • 4.1.5 Pulmonary Diseases Market, 2013-2018
      • 4.1.6 Neurological Disorders Market, 2013-2018
      • 4.1.7 Others Market, 2013-2018
    • 4.2 Market Forecast
      • 4.2.1 Oncology Market Forecast, 2019-2024
      • 4.2.2 Infectious Diseases Market Forecast, 2019-2024
      • 4.2.3 Rare Diseases Market Forecast, 2019-2024
      • 4.2.4 Autoimmune Diseases Market Forecast, 2019-2024
      • 4.2.5 Pulmonary Diseases Market Forecast, 2019-2024
      • 4.2.6 Neurological Disorders Market Forecast, 2019-2024
      • 4.2.7 Others Market Forecast, 2019-2024

    5 Market Segmentation by Application

    • 5.1 Market Size
      • 5.1.1 Hospital Market, 2013-2018
      • 5.1.2 Clinic Market, 2013-2018
      • 5.1.3 Research Institute Market, 2013-2018
      • 5.1.4 Laboratories Market, 2013-2018
    • 5.2 Market Forecast
      • 5.2.1 Hospital Market Forecast, 2019-2024
      • 5.2.2 Clinic Market Forecast, 2019-2024
      • 5.2.3 Research Institute Market Forecast, 2019-2024
      • 5.2.4 Laboratories Market Forecast, 2019-2024

    6 Market Segmentation by Region

    • 6.1 Market Size
      • 6.1.1 Asia-Pacific
        • 6.1.1.1 Asia-Pacific Market, 2012-2018
        • 6.1.1.2 Asia-Pacific Market by Type
        • 6.1.1.3 Asia-Pacific Market by Application
      • 6.1.2 North America
        • 6.1.2.1 North America Market, 2012-2018
        • 6.1.2.2 North America Market by Type
        • 6.1.2.3 North America Market by Application
      • 6.1.3 Europe
        • 6.1.3.1 Europe Market, 2012-2018
        • 6.1.3.2 Europe Market by Type
        • 6.1.3.3 Europe Market by Application
      • 6.1.4 South America
        • 6.1.4.1 South America Market, 2012-2018
        • 6.1.4.2 South America Market by Type
        • 6.1.4.3 South America Market by Application
      • 6.1.5 Middle East & Africa
        • 6.1.5.1 Middle East & Africa Market, 2012-2018
        • 6.1.5.2 Middle East & Africa Market by Type
        • 6.1.5.3 Middle East & Africa Market by Application
    • 6.2 Market Forecast
      • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
      • 6.2.2 North America Market Forecast, 2019-2024
      • 6.2.3 Europe Market Forecast, 2019-2024
      • 6.2.4 South America Market Forecast, 2019-2024
      • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

    7 Market Competitive

    • 7.1 Global Market by Vendors
    • 7.2 Market Concentration
    • 7.3 Price & Factors
    • 7.4 Marketing Channel

    8 Major Vendors

    • 8.1 Roche
    • 8.2 Abbvie
    • 8.3 Novartis International AG
    • 8.4 Janssen
    • 8.5 BMS
    • 8.6 Eli Lilly
    • 8.7 Gilead
    • 8.8 Sanofi
    • 8.9 Regeneron
    • 8.10 Acadia
    • 8.11 Boehringer Ingelheim
    • 8.12 Amgen
    • 8.13 AstraZeneca
    • 8.14 GlaxoSmithKline
    • 8.15 Vertex
    • 8.16 Alexion
    • 8.17 Merck
    • 8.18 Jazz Pharmaceuticals
    • 8.19 Exelixis
    • 8.20 Eisai
    • 8.21 Takeda
    • 8.22 Pfizer

    9 Conclusion

    Summary
    The global Breakthrough Therapy (BT) Designation market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    Oncology 
    Infectious Diseases 
    Rare Diseases 
    Autoimmune Diseases 
    Pulmonary Diseases 
    Neurological Disorders 
    Others
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    Roche 
    Abbvie 
    Novartis International AG 
    Janssen 
    BMS 
    Eli Lilly 
    Gilead 
    Sanofi 
    Regeneron 
    Acadia 
    Boehringer Ingelheim 
    Amgen 
    AstraZeneca 
    GlaxoSmithKline 
    Vertex 
    Alexion 
    Merck 
    Jazz Pharmaceuticals 
    Exelixis 
    Eisai 
    Takeda 
    Pfizer
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    Hospital 
    Clinic 
    Research Institute 
    Laboratories
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

    Buy now